Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as growing usage of nucleic acid molecules in various therapeutic areas.
Moreover, other factors such as growing advancement in the nucleic acid extraction and isolation techniques, growing demand for downstream applications such as Next Generation Sequencing (NGS) , targeted sequencing, etc. , drive the growth of Nucleic Acid Sample Preparation market.
Growing Research & Development in Life Sciences
Increasing investment by the government , academics & institutions, etc. to expand research in life science is expected to drive the market demand for Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified sciences LLC received a grant of approximately US$ 250,000 each, from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences ,is researching on advancing technology for pre diagnosis of cancer and other diseases. Similarly , Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.
Growing Usage of Nucleic Acid in Therapeutic Areas
The growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments ,distinct molecular procedures are developed and thus are increasing the nucleic acid samples extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.
Growing Demand for Nucleic Acid Extraction Systems
Nucleic acid isolation /extraction are the most basic steps involved in the molecular diagnosis or any molecular laboratory research and is expanding with the availability of distinct range of equipment and methods used for the extraction of samples. Availability of automated nucleic acid extraction systems are bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to run multiple number of samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. launched two new kits for viral RNA extraction with throat or nasal swab collection devices, which includes truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit .
Growing demand for Next generation Sequencing (Downstream applications)
The increased demand of Next-generation Sequencing (NGS) in disease is propelling the demand for Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing.
Recent Developments
Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. launched its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.
Market Segmentation
The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users and region. Based on product, the market is further segmented into consumables, systems and accessories & components. Based on technology, the market is further segmented into spin-column based technology, magnetic-bead based technology and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics and others. Based on end users, the marketed is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories and other. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
BGI Group (MGI Tech Co., Ltd.),
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Product Technology Therapeutic Area Application End users |
Regional Scope | North America, Asia Pacific, Europe, South America, Middle East & Africa |
Country Scope | United States, Canada, Mexico;,China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, Brazil, Argentina, Colombia, Saudi Arabia, UAE, South Africa, Kuwait |
Key Companies Profiled | BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |